The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as the country doubles …
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.